Global Digital Telepathology Market

Digital Telepathology Comprehensive Study by Type (Dynamic, Static, Hybrid), Application (Diagnosis, Education, Research, Others), End User (Hospitals, Diagnostic Centers and Pathology Clinics, Pharmaceutical and Biotech Companies, Academic Institutes, Research Organizations) Players and Region - Global Market Outlook to 2028

Digital Telepathology Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Digital Telepathology is the practice of remote pathology using telecommunication links to enable the electronic transmission of digital pathology images and it can be used for remotely rendering primary diagnoses, quality assurance, second opinion consultations, and research and education purposes. Digital Telepathology is used to aid a growing number of laboratories around the world to deliver pathology services by allowing them to easily connect with professionals. Telepathology is also used to enhance the efficiency of pathology services between hospitals less than a mile apart, and this has led to significant growth of the digital telepathology market over the forecast period.This growth is primarily driven by Increasing Clinical Urgency to Accept Telepathology to Improve Present Patient Diagnostic Imaging Events .

AttributesDetails
Study Period2018-2028
Base Year2022
Forecast Period2023-2028
Volume UnitN
Value UnitUSD (Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


The Health Care Services sector in the region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as GE Healthcare (United States), Leica Biosystems Nussloch GmbH (Germany), Ventana Medical Systems, Inc. (United States), Olympus Corporation (Japan), Koninklijke Philips N.V. (Netherlands), Mikroscan Technologies, Inc. (United States), Diagnostic Instruments Inc (United States), eVisit Telemedicine Solution (United States), Teleconsult Europe (Netherlands) and Unilabs (Switzerland), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
In December 2023, iCAD, a company specializing in AI-powered cancer diagnostics, has acquired Inspirata, a provider of digital pathology solutions. This merger will create a leading company in digital pathology and AI-powered cancer diagnostics.
In November 2023, Philips, a leading provider of healthcare technology, has partnered with UPMC, a major healthcare system in the US, to offer a digital telepathology platform for its network of hospitals and laboratories. This partnership will enable UPMC to improve access to pathology services for patients and physicians across its system.The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.

Influencing Trend:
Rising Digitalization and Information Technology across the Globe

Market Growth Drivers:
Increasing Clinical Urgency to Accept Telepathology to Improve Present Patient Diagnostic Imaging Events and High costs associated with Conventional Diagnostics is Driving the Growth of Digital Telepathology Market

Challenges:
Scarcity of Skilled Professionals is Hindering the Market Growth and Digital Telepathology has limited mostly to Large Academic Institutions

Restraints:
High Cost of Telepathology Devices

Opportunities:
Growing Prevalence of Chronic Diseases and Technological Advancements in the Healthcare Industry

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mainly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the market's growth. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Data Sources of Digital Telepathology Market Study

Primary Collection: InMail, LinkedIn Groups, Survey Monkey, Google, and Other professional Forums are some of the mediums utilized to gather primary data through key industry participants and appointees, subject-matter experts, C-level executives of Digital Telepathology Industry, among others including independent industry consultants, experts, to obtain and verify critical qualitative commentary and opinion and quantitative statistics, to assess future market prospects.

The primary interviews and data collected as per the below protocols:
• By Designation: C-Level, D-Level, Others
• By Company Type: Tier 1, Tier 2, Tier 3

Secondary Data Sources such as Annual reports, Press releases, Analyst meetings, Conference calls, Investor presentations, Management statements, and SEC filings of Digital Telepathology players along with Regulatory Sites, Association, World bank, etc were used as sources secondary set of data.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Digital Telepathology Study Sheds Light on
— The Digital Telepathology Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Digital Telepathology industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Digital Telepathology industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Dynamic
  • Static
  • Hybrid
By Application
  • Diagnosis
  • Education
  • Research
  • Others
By End User
  • Hospitals
  • Diagnostic Centers and Pathology Clinics
  • Pharmaceutical and Biotech Companies
  • Academic Institutes
  • Research Organizations

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Clinical Urgency to Accept Telepathology to Improve Present Patient Diagnostic Imaging Events
      • 3.2.2. High costs associated with Conventional Diagnostics is Driving the Growth of Digital Telepathology Market
    • 3.3. Market Challenges
      • 3.3.1. Scarcity of Skilled Professionals is Hindering the Market Growth
      • 3.3.2. Digital Telepathology has limited mostly to Large Academic Institutions
    • 3.4. Market Trends
      • 3.4.1. Rising Digitalization and Information Technology across the Globe
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Digital Telepathology, by Type, Application, End User and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Digital Telepathology (Value)
      • 5.2.1. Global Digital Telepathology by: Type (Value)
        • 5.2.1.1. Dynamic
        • 5.2.1.2. Static
        • 5.2.1.3. Hybrid
      • 5.2.2. Global Digital Telepathology by: Application (Value)
        • 5.2.2.1. Diagnosis
        • 5.2.2.2. Education
        • 5.2.2.3. Research
        • 5.2.2.4. Others
      • 5.2.3. Global Digital Telepathology by: End User (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Diagnostic Centers and Pathology Clinics
        • 5.2.3.3. Pharmaceutical and Biotech Companies
        • 5.2.3.4. Academic Institutes
        • 5.2.3.5. Research Organizations
      • 5.2.4. Global Digital Telepathology Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Digital Telepathology: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. GE Healthcare (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Leica Biosystems Nussloch GmbH (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Ventana Medical Systems, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Olympus Corporation (Japan)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Koninklijke Philips N.V. (Netherlands)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Mikroscan Technologies, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Diagnostic Instruments Inc (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. EVisit Telemedicine Solution (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Teleconsult Europe (Netherlands)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Unilabs (Switzerland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Digital Telepathology Sale, by Type, Application, End User and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Digital Telepathology (Value)
      • 7.2.1. Global Digital Telepathology by: Type (Value)
        • 7.2.1.1. Dynamic
        • 7.2.1.2. Static
        • 7.2.1.3. Hybrid
      • 7.2.2. Global Digital Telepathology by: Application (Value)
        • 7.2.2.1. Diagnosis
        • 7.2.2.2. Education
        • 7.2.2.3. Research
        • 7.2.2.4. Others
      • 7.2.3. Global Digital Telepathology by: End User (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Diagnostic Centers and Pathology Clinics
        • 7.2.3.3. Pharmaceutical and Biotech Companies
        • 7.2.3.4. Academic Institutes
        • 7.2.3.5. Research Organizations
      • 7.2.4. Global Digital Telepathology Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Digital Telepathology: by Type(USD Million)
  • Table 2. Digital Telepathology Dynamic , by Region USD Million (2017-2022)
  • Table 3. Digital Telepathology Static , by Region USD Million (2017-2022)
  • Table 4. Digital Telepathology Hybrid , by Region USD Million (2017-2022)
  • Table 5. Digital Telepathology: by Application(USD Million)
  • Table 6. Digital Telepathology Diagnosis , by Region USD Million (2017-2022)
  • Table 7. Digital Telepathology Education , by Region USD Million (2017-2022)
  • Table 8. Digital Telepathology Research , by Region USD Million (2017-2022)
  • Table 9. Digital Telepathology Others , by Region USD Million (2017-2022)
  • Table 10. Digital Telepathology: by End User(USD Million)
  • Table 11. Digital Telepathology Hospitals , by Region USD Million (2017-2022)
  • Table 12. Digital Telepathology Diagnostic Centers and Pathology Clinics , by Region USD Million (2017-2022)
  • Table 13. Digital Telepathology Pharmaceutical and Biotech Companies , by Region USD Million (2017-2022)
  • Table 14. Digital Telepathology Academic Institutes , by Region USD Million (2017-2022)
  • Table 15. Digital Telepathology Research Organizations , by Region USD Million (2017-2022)
  • Table 16. South America Digital Telepathology, by Country USD Million (2017-2022)
  • Table 17. South America Digital Telepathology, by Type USD Million (2017-2022)
  • Table 18. South America Digital Telepathology, by Application USD Million (2017-2022)
  • Table 19. South America Digital Telepathology, by End User USD Million (2017-2022)
  • Table 20. Brazil Digital Telepathology, by Type USD Million (2017-2022)
  • Table 21. Brazil Digital Telepathology, by Application USD Million (2017-2022)
  • Table 22. Brazil Digital Telepathology, by End User USD Million (2017-2022)
  • Table 23. Argentina Digital Telepathology, by Type USD Million (2017-2022)
  • Table 24. Argentina Digital Telepathology, by Application USD Million (2017-2022)
  • Table 25. Argentina Digital Telepathology, by End User USD Million (2017-2022)
  • Table 26. Rest of South America Digital Telepathology, by Type USD Million (2017-2022)
  • Table 27. Rest of South America Digital Telepathology, by Application USD Million (2017-2022)
  • Table 28. Rest of South America Digital Telepathology, by End User USD Million (2017-2022)
  • Table 29. Asia Pacific Digital Telepathology, by Country USD Million (2017-2022)
  • Table 30. Asia Pacific Digital Telepathology, by Type USD Million (2017-2022)
  • Table 31. Asia Pacific Digital Telepathology, by Application USD Million (2017-2022)
  • Table 32. Asia Pacific Digital Telepathology, by End User USD Million (2017-2022)
  • Table 33. China Digital Telepathology, by Type USD Million (2017-2022)
  • Table 34. China Digital Telepathology, by Application USD Million (2017-2022)
  • Table 35. China Digital Telepathology, by End User USD Million (2017-2022)
  • Table 36. Japan Digital Telepathology, by Type USD Million (2017-2022)
  • Table 37. Japan Digital Telepathology, by Application USD Million (2017-2022)
  • Table 38. Japan Digital Telepathology, by End User USD Million (2017-2022)
  • Table 39. India Digital Telepathology, by Type USD Million (2017-2022)
  • Table 40. India Digital Telepathology, by Application USD Million (2017-2022)
  • Table 41. India Digital Telepathology, by End User USD Million (2017-2022)
  • Table 42. South Korea Digital Telepathology, by Type USD Million (2017-2022)
  • Table 43. South Korea Digital Telepathology, by Application USD Million (2017-2022)
  • Table 44. South Korea Digital Telepathology, by End User USD Million (2017-2022)
  • Table 45. Taiwan Digital Telepathology, by Type USD Million (2017-2022)
  • Table 46. Taiwan Digital Telepathology, by Application USD Million (2017-2022)
  • Table 47. Taiwan Digital Telepathology, by End User USD Million (2017-2022)
  • Table 48. Australia Digital Telepathology, by Type USD Million (2017-2022)
  • Table 49. Australia Digital Telepathology, by Application USD Million (2017-2022)
  • Table 50. Australia Digital Telepathology, by End User USD Million (2017-2022)
  • Table 51. Rest of Asia-Pacific Digital Telepathology, by Type USD Million (2017-2022)
  • Table 52. Rest of Asia-Pacific Digital Telepathology, by Application USD Million (2017-2022)
  • Table 53. Rest of Asia-Pacific Digital Telepathology, by End User USD Million (2017-2022)
  • Table 54. Europe Digital Telepathology, by Country USD Million (2017-2022)
  • Table 55. Europe Digital Telepathology, by Type USD Million (2017-2022)
  • Table 56. Europe Digital Telepathology, by Application USD Million (2017-2022)
  • Table 57. Europe Digital Telepathology, by End User USD Million (2017-2022)
  • Table 58. Germany Digital Telepathology, by Type USD Million (2017-2022)
  • Table 59. Germany Digital Telepathology, by Application USD Million (2017-2022)
  • Table 60. Germany Digital Telepathology, by End User USD Million (2017-2022)
  • Table 61. France Digital Telepathology, by Type USD Million (2017-2022)
  • Table 62. France Digital Telepathology, by Application USD Million (2017-2022)
  • Table 63. France Digital Telepathology, by End User USD Million (2017-2022)
  • Table 64. Italy Digital Telepathology, by Type USD Million (2017-2022)
  • Table 65. Italy Digital Telepathology, by Application USD Million (2017-2022)
  • Table 66. Italy Digital Telepathology, by End User USD Million (2017-2022)
  • Table 67. United Kingdom Digital Telepathology, by Type USD Million (2017-2022)
  • Table 68. United Kingdom Digital Telepathology, by Application USD Million (2017-2022)
  • Table 69. United Kingdom Digital Telepathology, by End User USD Million (2017-2022)
  • Table 70. Netherlands Digital Telepathology, by Type USD Million (2017-2022)
  • Table 71. Netherlands Digital Telepathology, by Application USD Million (2017-2022)
  • Table 72. Netherlands Digital Telepathology, by End User USD Million (2017-2022)
  • Table 73. Rest of Europe Digital Telepathology, by Type USD Million (2017-2022)
  • Table 74. Rest of Europe Digital Telepathology, by Application USD Million (2017-2022)
  • Table 75. Rest of Europe Digital Telepathology, by End User USD Million (2017-2022)
  • Table 76. MEA Digital Telepathology, by Country USD Million (2017-2022)
  • Table 77. MEA Digital Telepathology, by Type USD Million (2017-2022)
  • Table 78. MEA Digital Telepathology, by Application USD Million (2017-2022)
  • Table 79. MEA Digital Telepathology, by End User USD Million (2017-2022)
  • Table 80. Middle East Digital Telepathology, by Type USD Million (2017-2022)
  • Table 81. Middle East Digital Telepathology, by Application USD Million (2017-2022)
  • Table 82. Middle East Digital Telepathology, by End User USD Million (2017-2022)
  • Table 83. Africa Digital Telepathology, by Type USD Million (2017-2022)
  • Table 84. Africa Digital Telepathology, by Application USD Million (2017-2022)
  • Table 85. Africa Digital Telepathology, by End User USD Million (2017-2022)
  • Table 86. North America Digital Telepathology, by Country USD Million (2017-2022)
  • Table 87. North America Digital Telepathology, by Type USD Million (2017-2022)
  • Table 88. North America Digital Telepathology, by Application USD Million (2017-2022)
  • Table 89. North America Digital Telepathology, by End User USD Million (2017-2022)
  • Table 90. United States Digital Telepathology, by Type USD Million (2017-2022)
  • Table 91. United States Digital Telepathology, by Application USD Million (2017-2022)
  • Table 92. United States Digital Telepathology, by End User USD Million (2017-2022)
  • Table 93. Canada Digital Telepathology, by Type USD Million (2017-2022)
  • Table 94. Canada Digital Telepathology, by Application USD Million (2017-2022)
  • Table 95. Canada Digital Telepathology, by End User USD Million (2017-2022)
  • Table 96. Mexico Digital Telepathology, by Type USD Million (2017-2022)
  • Table 97. Mexico Digital Telepathology, by Application USD Million (2017-2022)
  • Table 98. Mexico Digital Telepathology, by End User USD Million (2017-2022)
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Digital Telepathology: by Type(USD Million)
  • Table 110. Digital Telepathology Dynamic , by Region USD Million (2023-2028)
  • Table 111. Digital Telepathology Static , by Region USD Million (2023-2028)
  • Table 112. Digital Telepathology Hybrid , by Region USD Million (2023-2028)
  • Table 113. Digital Telepathology: by Application(USD Million)
  • Table 114. Digital Telepathology Diagnosis , by Region USD Million (2023-2028)
  • Table 115. Digital Telepathology Education , by Region USD Million (2023-2028)
  • Table 116. Digital Telepathology Research , by Region USD Million (2023-2028)
  • Table 117. Digital Telepathology Others , by Region USD Million (2023-2028)
  • Table 118. Digital Telepathology: by End User(USD Million)
  • Table 119. Digital Telepathology Hospitals , by Region USD Million (2023-2028)
  • Table 120. Digital Telepathology Diagnostic Centers and Pathology Clinics , by Region USD Million (2023-2028)
  • Table 121. Digital Telepathology Pharmaceutical and Biotech Companies , by Region USD Million (2023-2028)
  • Table 122. Digital Telepathology Academic Institutes , by Region USD Million (2023-2028)
  • Table 123. Digital Telepathology Research Organizations , by Region USD Million (2023-2028)
  • Table 124. South America Digital Telepathology, by Country USD Million (2023-2028)
  • Table 125. South America Digital Telepathology, by Type USD Million (2023-2028)
  • Table 126. South America Digital Telepathology, by Application USD Million (2023-2028)
  • Table 127. South America Digital Telepathology, by End User USD Million (2023-2028)
  • Table 128. Brazil Digital Telepathology, by Type USD Million (2023-2028)
  • Table 129. Brazil Digital Telepathology, by Application USD Million (2023-2028)
  • Table 130. Brazil Digital Telepathology, by End User USD Million (2023-2028)
  • Table 131. Argentina Digital Telepathology, by Type USD Million (2023-2028)
  • Table 132. Argentina Digital Telepathology, by Application USD Million (2023-2028)
  • Table 133. Argentina Digital Telepathology, by End User USD Million (2023-2028)
  • Table 134. Rest of South America Digital Telepathology, by Type USD Million (2023-2028)
  • Table 135. Rest of South America Digital Telepathology, by Application USD Million (2023-2028)
  • Table 136. Rest of South America Digital Telepathology, by End User USD Million (2023-2028)
  • Table 137. Asia Pacific Digital Telepathology, by Country USD Million (2023-2028)
  • Table 138. Asia Pacific Digital Telepathology, by Type USD Million (2023-2028)
  • Table 139. Asia Pacific Digital Telepathology, by Application USD Million (2023-2028)
  • Table 140. Asia Pacific Digital Telepathology, by End User USD Million (2023-2028)
  • Table 141. China Digital Telepathology, by Type USD Million (2023-2028)
  • Table 142. China Digital Telepathology, by Application USD Million (2023-2028)
  • Table 143. China Digital Telepathology, by End User USD Million (2023-2028)
  • Table 144. Japan Digital Telepathology, by Type USD Million (2023-2028)
  • Table 145. Japan Digital Telepathology, by Application USD Million (2023-2028)
  • Table 146. Japan Digital Telepathology, by End User USD Million (2023-2028)
  • Table 147. India Digital Telepathology, by Type USD Million (2023-2028)
  • Table 148. India Digital Telepathology, by Application USD Million (2023-2028)
  • Table 149. India Digital Telepathology, by End User USD Million (2023-2028)
  • Table 150. South Korea Digital Telepathology, by Type USD Million (2023-2028)
  • Table 151. South Korea Digital Telepathology, by Application USD Million (2023-2028)
  • Table 152. South Korea Digital Telepathology, by End User USD Million (2023-2028)
  • Table 153. Taiwan Digital Telepathology, by Type USD Million (2023-2028)
  • Table 154. Taiwan Digital Telepathology, by Application USD Million (2023-2028)
  • Table 155. Taiwan Digital Telepathology, by End User USD Million (2023-2028)
  • Table 156. Australia Digital Telepathology, by Type USD Million (2023-2028)
  • Table 157. Australia Digital Telepathology, by Application USD Million (2023-2028)
  • Table 158. Australia Digital Telepathology, by End User USD Million (2023-2028)
  • Table 159. Rest of Asia-Pacific Digital Telepathology, by Type USD Million (2023-2028)
  • Table 160. Rest of Asia-Pacific Digital Telepathology, by Application USD Million (2023-2028)
  • Table 161. Rest of Asia-Pacific Digital Telepathology, by End User USD Million (2023-2028)
  • Table 162. Europe Digital Telepathology, by Country USD Million (2023-2028)
  • Table 163. Europe Digital Telepathology, by Type USD Million (2023-2028)
  • Table 164. Europe Digital Telepathology, by Application USD Million (2023-2028)
  • Table 165. Europe Digital Telepathology, by End User USD Million (2023-2028)
  • Table 166. Germany Digital Telepathology, by Type USD Million (2023-2028)
  • Table 167. Germany Digital Telepathology, by Application USD Million (2023-2028)
  • Table 168. Germany Digital Telepathology, by End User USD Million (2023-2028)
  • Table 169. France Digital Telepathology, by Type USD Million (2023-2028)
  • Table 170. France Digital Telepathology, by Application USD Million (2023-2028)
  • Table 171. France Digital Telepathology, by End User USD Million (2023-2028)
  • Table 172. Italy Digital Telepathology, by Type USD Million (2023-2028)
  • Table 173. Italy Digital Telepathology, by Application USD Million (2023-2028)
  • Table 174. Italy Digital Telepathology, by End User USD Million (2023-2028)
  • Table 175. United Kingdom Digital Telepathology, by Type USD Million (2023-2028)
  • Table 176. United Kingdom Digital Telepathology, by Application USD Million (2023-2028)
  • Table 177. United Kingdom Digital Telepathology, by End User USD Million (2023-2028)
  • Table 178. Netherlands Digital Telepathology, by Type USD Million (2023-2028)
  • Table 179. Netherlands Digital Telepathology, by Application USD Million (2023-2028)
  • Table 180. Netherlands Digital Telepathology, by End User USD Million (2023-2028)
  • Table 181. Rest of Europe Digital Telepathology, by Type USD Million (2023-2028)
  • Table 182. Rest of Europe Digital Telepathology, by Application USD Million (2023-2028)
  • Table 183. Rest of Europe Digital Telepathology, by End User USD Million (2023-2028)
  • Table 184. MEA Digital Telepathology, by Country USD Million (2023-2028)
  • Table 185. MEA Digital Telepathology, by Type USD Million (2023-2028)
  • Table 186. MEA Digital Telepathology, by Application USD Million (2023-2028)
  • Table 187. MEA Digital Telepathology, by End User USD Million (2023-2028)
  • Table 188. Middle East Digital Telepathology, by Type USD Million (2023-2028)
  • Table 189. Middle East Digital Telepathology, by Application USD Million (2023-2028)
  • Table 190. Middle East Digital Telepathology, by End User USD Million (2023-2028)
  • Table 191. Africa Digital Telepathology, by Type USD Million (2023-2028)
  • Table 192. Africa Digital Telepathology, by Application USD Million (2023-2028)
  • Table 193. Africa Digital Telepathology, by End User USD Million (2023-2028)
  • Table 194. North America Digital Telepathology, by Country USD Million (2023-2028)
  • Table 195. North America Digital Telepathology, by Type USD Million (2023-2028)
  • Table 196. North America Digital Telepathology, by Application USD Million (2023-2028)
  • Table 197. North America Digital Telepathology, by End User USD Million (2023-2028)
  • Table 198. United States Digital Telepathology, by Type USD Million (2023-2028)
  • Table 199. United States Digital Telepathology, by Application USD Million (2023-2028)
  • Table 200. United States Digital Telepathology, by End User USD Million (2023-2028)
  • Table 201. Canada Digital Telepathology, by Type USD Million (2023-2028)
  • Table 202. Canada Digital Telepathology, by Application USD Million (2023-2028)
  • Table 203. Canada Digital Telepathology, by End User USD Million (2023-2028)
  • Table 204. Mexico Digital Telepathology, by Type USD Million (2023-2028)
  • Table 205. Mexico Digital Telepathology, by Application USD Million (2023-2028)
  • Table 206. Mexico Digital Telepathology, by End User USD Million (2023-2028)
  • Table 207. Research Programs/Design for This Report
  • Table 208. Key Data Information from Secondary Sources
  • Table 209. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Digital Telepathology: by Type USD Million (2017-2022)
  • Figure 5. Global Digital Telepathology: by Application USD Million (2017-2022)
  • Figure 6. Global Digital Telepathology: by End User USD Million (2017-2022)
  • Figure 7. South America Digital Telepathology Share (%), by Country
  • Figure 8. Asia Pacific Digital Telepathology Share (%), by Country
  • Figure 9. Europe Digital Telepathology Share (%), by Country
  • Figure 10. MEA Digital Telepathology Share (%), by Country
  • Figure 11. North America Digital Telepathology Share (%), by Country
  • Figure 12. Global Digital Telepathology share by Players 2022 (%)
  • Figure 13. Global Digital Telepathology share by Players (Top 3) 2022(%)
  • Figure 14. Global Digital Telepathology share by Players (Top 5) 2022(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. GE Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 17. GE Healthcare (United States) Revenue: by Geography 2022
  • Figure 18. Leica Biosystems Nussloch GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 19. Leica Biosystems Nussloch GmbH (Germany) Revenue: by Geography 2022
  • Figure 20. Ventana Medical Systems, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Ventana Medical Systems, Inc. (United States) Revenue: by Geography 2022
  • Figure 22. Olympus Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 23. Olympus Corporation (Japan) Revenue: by Geography 2022
  • Figure 24. Koninklijke Philips N.V. (Netherlands) Revenue, Net Income and Gross profit
  • Figure 25. Koninklijke Philips N.V. (Netherlands) Revenue: by Geography 2022
  • Figure 26. Mikroscan Technologies, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. Mikroscan Technologies, Inc. (United States) Revenue: by Geography 2022
  • Figure 28. Diagnostic Instruments Inc (United States) Revenue, Net Income and Gross profit
  • Figure 29. Diagnostic Instruments Inc (United States) Revenue: by Geography 2022
  • Figure 30. EVisit Telemedicine Solution (United States) Revenue, Net Income and Gross profit
  • Figure 31. EVisit Telemedicine Solution (United States) Revenue: by Geography 2022
  • Figure 32. Teleconsult Europe (Netherlands) Revenue, Net Income and Gross profit
  • Figure 33. Teleconsult Europe (Netherlands) Revenue: by Geography 2022
  • Figure 34. Unilabs (Switzerland) Revenue, Net Income and Gross profit
  • Figure 35. Unilabs (Switzerland) Revenue: by Geography 2022
  • Figure 36. Global Digital Telepathology: by Type USD Million (2023-2028)
  • Figure 37. Global Digital Telepathology: by Application USD Million (2023-2028)
  • Figure 38. Global Digital Telepathology: by End User USD Million (2023-2028)
  • Figure 39. South America Digital Telepathology Share (%), by Country
  • Figure 40. Asia Pacific Digital Telepathology Share (%), by Country
  • Figure 41. Europe Digital Telepathology Share (%), by Country
  • Figure 42. MEA Digital Telepathology Share (%), by Country
  • Figure 43. North America Digital Telepathology Share (%), by Country
List of companies from research coverage that are profiled in the study
  • GE Healthcare (United States)
  • Leica Biosystems Nussloch GmbH (Germany)
  • Ventana Medical Systems, Inc. (United States)
  • Olympus Corporation (Japan)
  • Koninklijke Philips N.V. (Netherlands)
  • Mikroscan Technologies, Inc. (United States)
  • Diagnostic Instruments Inc (United States)
  • eVisit Telemedicine Solution (United States)
  • Teleconsult Europe (Netherlands)
  • Unilabs (Switzerland)
Additional players considered in the study are as follows:
SRL Diagnostics (India) , Apollo Tele Health Services (India)
Select User Access Type

Key Highlights of Report


Dec 2023 209 Pages 56 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Digital Telepathology Market Quantitative research analysis
Global Digital Telepathology Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2018-2022; Base year: 2022; Forecast period: 2023 to 2028
Companies that are profiled in Global Digital Telepathology Market are GE Healthcare (United States), Leica Biosystems Nussloch GmbH (Germany), Ventana Medical Systems, Inc. (United States), Olympus Corporation (Japan), Koninklijke Philips N.V. (Netherlands), Mikroscan Technologies, Inc. (United States), Diagnostic Instruments Inc (United States), eVisit Telemedicine Solution (United States), Teleconsult Europe (Netherlands) and Unilabs (Switzerland) etc.
Diagnosis segment in Global market to hold robust market share owing to "Increasing Clinical Urgency to Accept Telepathology to Improve Present Patient Diagnostic Imaging Events ".
AMA Research predicts that United States Players will contribute to the maximum growth of Global Digital Telepathology market throughout the forecasted period.

Know More About Global Digital Telepathology Market Report?

Have a Query? Click Here

Other Related Reports

Medical Consultation Service Comprehensive Study by Indication (Cardiology, Dermatology, Diabetes Consultation, Gastroenterology, General Physician, Gynecology, Neurology, Oncology, Orthopedics, Othe...
$ 3350
Heart Failure Testing Comprehensive Study by Type (Blood tests, Chest X-ray, Electrocardiogram (ECG), Echocardiogram, Others (Stress test, CT, MRI, Coronary Angiogram)), Application (Myocardial Infar...
$ 3750
Clinical Electrophoresis Comprehensive Study by Type (Routine (Zone) Electrophoresis, High Resolution (HRE) Electrophoresis, Polyacrylamide (PAGE) Electrophoresis, Capillary (CE) Electrophoresis, Iso...
$ 3750
Novel Cell Sorting and Separation Comprehensive Study by Type (Cancer Cell, Immune Cells, Microbial Cell, Red Blood Cell/Platelet, Stem Cell, Others), Application (Academic Institutes, Clinical Testi...
$ 3750
Network Connected Medical Devices Comprehensive Study by Type (Wearable, Implantable Device), Application (Hospital, Clinic, Other), Connectivity (BLE, Wi-Fi, NFC, Cellular), Devices (Patient Monitor...
$ 3650
Intramuscular Drug Delivery Comprehensive Study by Type (Oral (Swallowed Into The Stomach), Intravenous (Injected Into The Vein), Subcutaneous (Injected Into The Fatty Tissue Just Under The Layer Of ...
$ 3750